The Quality and Performance Measures Workgroup is working to identify gaps in quality and performance improvement measures for adult immunizations, work with partners to encourage the development of appropriate adult immunization performance measures, and promote the use of such adult immunization measures to increase the overall rates of adult immunization.
MEETING SCHEDULE
The Quality and Performance Measures Workgroup meets quarterly on Wednesdays at 12 p.m. (ET).
Meeting Archives
February 20, 2019
November 5, 2018
June 18, 2018
- Presentation Slides:
February 26, 2018
- Presentation Slides:
October 2, 2017
- Presentation Slides:
August 21, 2017
- Presentation Slides:
June 12, 2017
- Presentation Slides:
May 15, 2017
- Presentation Slides:
April 17, 2017
January 23, 2017
November 28, 2016
- Presentation Slides:
Projects
Advancing Immunization Measures for End-Stage Renal Disease Patients: Recommendations of the National Adult and Immunization Summit (NAIIS) – April 18, 2018
The End Stage Renal Disease (ESRD) subgroup developed a set of recommendations to CMS on potential means to improve End Stage Renal Disease (ESRD) quality programs in the Medicare ESRD population.
Priority Setting for Health Care Performance Measurement: Addressing Performance Measure Gaps in Priority Areas
The working group provided input to efforts to identify gaps in the development and implementation of adult immunization quality measures, and helped shape initiatives to address these gaps, including the National Quality Forum (NQF) adult immunization project, and the initial efforts to develop a national immunization plan.
Resources
Shen AK, Bridges CB, Tan L. The first national adult immunization summit 2012: implementing change through action. Vaccine. 2013 Jan 2;31(2):279-84. doi: 10.1016/j.vaccine.2012.11.033. Epub 2012 Nov 19.
Shen AK, Groom AV, Leach DL, Bridges CB, Tsai AY, Tan L. A pathway to developing and testing quality measures aimed at improving adult vaccination rates in the United States. Vaccine. 2019 Feb 28;37(10):1277-1283. doi: 10.1016/j.vaccine.2019.01.044. Epub 2019 Feb 6.